by in
Entry Author Date Location
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Stealth Mode is the New Sweet Spot for Some Biotechs 07/14/14 National
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs 10/02/13 Boston
Roche & Isis Join Forces on Antisense Drug for Huntington’s Disease 04/08/13 San Diego
ENCODE and the Truth 03/29/13 Seattle
Biology 101 01/18/12 Boston
Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News 09/09/11 Boston
Sanofi Bids for Genzyme, ModeRNA Announces Stem Cell Tech, Health IT Execs Debate, & More Boston Area Life Sciences News 10/08/10 Boston
The Decade’s Most Important Biomedical Discovery 12/18/09 Boston
AVI Nabs $11.5M Defense Contract 10/05/09 Seattle
AVI Biopharma Settles Into New Digs, Scopes Out Seattle Biotech Talent Pool 09/29/09 Seattle
AVI Nails Down $30M 08/20/09 Seattle
AVI Ends June With $20M Cash 08/10/09 Seattle
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent 07/30/09 Seattle
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News 07/30/09 Seattle
$3M for IntelligentMDx 06/29/09 Boston
Alnylam Invests $5M in Canadian RNAi Company 06/02/08 Boston
High Hopes and Expectations About Tomorrow’s Science and Technology Challenge 05/27/08 Boston
Archemix Pulls IPO 02/07/08 Boston
Archemix Sets IPO Terms 10/23/07 Boston
Page 1 of 1